Morgan Stanley Alpha Tau Medical Ltd. Call Options Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DRTS
# of Institutions
30Shares Held
1.92MCall Options Held
0Put Options Held
0-
Levin Capital Strategies, L.P. New York, NY339KShares$748,6680.1% of portfolio
-
Hoyle Cohen, LLC269KShares$594,6840.06% of portfolio
-
Corbin Capital Partners, L.P. New York, NY260KShares$574,8401.86% of portfolio
-
High Tower Advisors, LLC Chicago, IL213KShares$469,6420.0% of portfolio
-
Atalaya Capital Management LP New York, NY73.7KShares$162,9690.57% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $153M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...